Assembly Biosciences, Inc. is a clinical-stage biotechnology company in the United States. The company is headquartered in South San Francisco, California. Show more

TWO TOWER PLACE, SOUTH SAN FRANCISCO, CA, UNITED STATES, 94080, South San Francisco, CA, 94080, USA

https://www.assemblybio.com

BIOTECHNOLOGY

HEALTHCARE

Start AI Chat

Market Cap

670.9M

52 Wk Range

$20.23 - $39.71

Previous Close

$29.95

Open

$30.08

Volume

559,108

Day Range

$29.78 - $33.16

Enterprise Value

305.8M

Cash

32.29M

Avg Qtr Burn

-15.49M

Insider Ownership

28.42%

Institutional Own.

57.46%

Qtr Updated

06/30/26

Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.

Drug & Indication	Stage & Event	Catalyst Date
ABI-6250 (NTCP Inhibitor) Details Primary Biliary Cholangitis And Primary Sclerosing Cholangitis	Phase 2 Initiation	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.
ABI-1179 Details Long-acting herpes simplex virus (HSV)	Phase 1b Update	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.
ABI-5366 Details Recurrent Genital Herpes Simplex Type 2	Phase 1b Update	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.
ABI-4334 Details Chronic hepatitis B virus (HBV)	Phase 1 Update	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.
ABI-6250 Details Chronic hepatitis delta virus (HDV)	Phase 1a Update	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.
Vebicorvir (VBR, ABI-H0731) Details Liver infection, Chronic liver disease, Hepatitis B	Failed Discontinued	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.
ABI-H2158 Details Liver infection, Liver disease, Hepatitis B	Failed Discontinued	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.
ABI-H3733 Details Liver disease, Hepatitis B, Liver infection	Failed Discontinued	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.